N. Barbet

发表

French experience with contact X-ray endocavitary radiation for early rectal cancer.

P. Romestaing, J. Gérard, O. Chapet, 2007, Clinical oncology (Royal College of Radiologists (Great Britain)).

Improved sphincter preservation in low rectal cancer with high-dose preoperative radiotherapy: the lyon R96-02 randomized trial.

P. Adeleine, P. Maingon, P. Romestaing, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

New Neoadjuvant Treatment Strategies for Non-Metastatic Rectal Cancer (M0)

J. Gérard, J. Doyen, N. Barbet, 2015, Current Colorectal Cancer Reports.

Planned organ preservation for early T2-3 rectal adenocarcinoma: A French, multicentre study.

R. Schiappa, J. Gugenheim, J. Gérard, 2019, European journal of cancer.

Contact X-ray brachytherapy for rectal cancer: Past, present, and future.

J. Gérard, J. Hannoun-levi, C. Dejean, 2021, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

Benefits and challenges of standard ceiling-mounted surface guided radiotherapy systems for breast treatments on Halcyon™

D. Nguyen, J. Farah, N. Barbet, 2021, Radioprotection.

Benefits and challenges of standard ceiling-mounted surface guided radiotherapy systems for breast treatments on HalcyonTM

D. Nguyen, J. Farah, N. Barbet, 2021 .

Phase I clinical and pharmacokinetic study of S9788, a new multidrug-resistance reversal agent given alone and in combination with doxorubicin to patients with advanced solid tumors

C. Ardiet, G. Bastian, B. Tranchand, 1998, Cancer Chemotherapy and Pharmacology.

Preoperative concurrent chemoradiation in locally advanced rectal cancer with 50 Gy and oxaliplatin (OXA), fluorouracil (FU), I-folinic acid (l-LV). The lyon R0-04 phase II trial

P. Romestaing, J. Gérard, F. Mornex, 2002 .

Cisplatin-induced hyponatremia and renal sodium wasting.

V. Cottin, C. Thieblemont, N. Barbet, 1995, Acta oncologica.

[Double-blinded controlled study comparing clodronate versus placebo in patients with breast cancer bone metastases].

L. Mauriac, M. Tubiana-Hulin, A. Monnier, 2001, Bulletin du cancer.

Targeted Radiotherapy Using Contact X-ray Brachytherapy 50 kV

T. Vuong, J. Gérard, J. Gal, 2022, Cancers.

Reproducibility of Deep-Inspiration Breath Hold treatments on Halcyon™ performed using the first clinical version of AlignRT InBore™: Results of CYBORE study

J. Farah, F. Lorchel, N. Barbet, 2022, Clinical and translational radiation oncology.

Combined curative radiation therapy alone in (T1) T2-3 rectal adenocarcinoma: a pilot study of 29 patients.

J. Thalabard, P. Romestaing, J. Gérard, 1996, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Salvage liver surgery of a chemorefractory ovarian choriocarcinoma.

I. Treilleux, J. Droz, M. Rivoire, 1997, Gynecologic oncology.

Organ preservation in rectal adenocarcinoma (T1) T2-T3 Nx M0. Historical overview of the Lyon Sud – Nice experience using contact x-ray brachytherapy and external beam radiotherapy for 120 patients

S. Marcié, P. Romestaing, J. Gérard, 2015, Acta oncologica.

[Treatment of eyelid carcinomas of 2 cmm or less by contact radiotherapy].

A. Pica, P. Romestaing, J. Gérard, 1996, Journal francais d'ophtalmologie.

Endocavitary irradiation for early rectal carcinomas T1 (T2). A series of 101 patients treated with the Papillon's technique.

P. Romestaing, J. Gérard, F. Rocher, 1996, International journal of radiation oncology, biology, physics.

Medulloblastoma in adults: survival and prognostic factors.

J. Blay, E. Bouffet, C. Lasset, 1993, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

P. Romestaing, P. Heudel, G. Freyer, 2008, Clinical oncology (Royal College of Radiologists (Great Britain)).

Preoperative concurrent chemoradiotherapy in locally advanced rectal cancer with high-dose radiation and oxaliplatin-containing regimen: the Lyon R0-04 phase II trial.

P. Adeleine, P. Romestaing, J. Gérard, 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemoradiotherapy with radiation dose escalation with contact x-ray brachytherapy boost or external beam radiotherapy boost for organ preservation in early cT2-cT3 rectal adenocarcinoma (OPERA): a phase 3, randomised controlled trial.

R. Schiappa, L. Mineur, J. Gérard, 2023, The lancet. Gastroenterology & hepatology.

Complete remission of a primary cutaneous B cell lymphoma treated with intralesional recombinant interferon alpha-2a.

T. Zénone, N. Barbet, G. Catimel, 1994, European journal of cancer.

Contact x-ray brachytherapy (Papillon) in addition to chemoradiotherapy to improve organ preservation in early cT2-T3 rectal adenocarcinoma: The 3-year results of OPERA randomized trial (NCT02505750).

N. Magné, L. Mineur, J. Gérard, 2022, Journal of Clinical Oncology.

6 months versus 12 months of adjuvant trastuzumab in early breast cancer (PHARE): final analysis of a multicentre, open-label, phase 3 randomised trial

C. Tournigand, M. Espié, B. Weber, 2019, The Lancet.

[Local excision and adjuvant radiotherapy for rectal adenocarcinoma T1-2 N0].

P. Romestaing, J. Gérard, F. Mornex, 2000, Gastroenterologie clinique et biologique.

Capecitabine, irinotecan, oxaliplatin (CAPIRINOX) and concomitant irradiation in advanced rectal cancer: the Lyon R-02-01 phase I trial.

P. Heudel, C. Falandry, N. Barbet, 2008, Clinics in oncology.

Reproducibility of surface-based deep inspiration breath-hold technique for lung stereotactic body radiotherapy on a closed-bore gantry linac

J. Farah, F. Lorchel, E. Louet, 2023, Physics and imaging in radiation oncology.

[Adjuvant contact radiotherapy for conjunctival malignancies: Preliminary results of a series of 14 patients treated with the Papillon 50 machine].

G. Largeron, T. Mathis, J. Grangé, 2018, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.

'Folfirinox' chemotherapy combined with contact x-ray brachytherapy 50kVp and 'CAP50' chemoradiotherapy aiming at organ preservation for selected intermediate distal-middle cT2-T3 rectal cancers: A feasibility study.

L. Mineur, J. Durand-Labrunie, N. Barbet, 2024, Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique.